Aminoglycoside Antibiotic — Ophthalmic
Pregnancy: Topical use — considered low risk; minimal systemic absorption
Tobramycin Eye Drops 0.3% / Ointment
Brand names: Tobrex
Adult dose
Dose: 1–2 drops every 4 hours (drops); 1 cm ointment three times daily (ointment)
Route: Topical (ophthalmic)
Frequency: Every 4 hours (drops) or three times daily (ointment); hourly for severe keratitis
Max: 1–2 drops per dose
Ointment formulation preferred overnight for sustained coverage. Combined with dexamethasone in Tobradex for inflammatory bacterial conditions. Active against Pseudomonas aeruginosa and most Gram-negative bacteria.
Paediatric dose
Route: Topical
Frequency: Every 4–6 hours
Max: Same as adult
Used in paediatric bacterial eye infections; Tobradex (tobramycin + dexamethasone) has age restrictions — seek specialist guidance in children <2 years
Dose adjustments
Renal
No systemic absorption at topical doses — no adjustment required
Hepatic
No adjustment required
Clinical pearls
- Pseudomonas aeruginosa keratitis: contact lens wearers are particularly susceptible — tobramycin or ciprofloxacin hourly (alternating) is the standard aggressive treatment; urgent ophthalmology referral mandatory
- Tobradex (tobramycin 0.3% + dexamethasone 0.1%): used for blepharoconjunctivitis with inflammatory component — dexamethasone component is contraindicated if herpes simplex keratitis cannot be excluded; always confirm dendritic ulcers absent with fluorescein before prescribing
- Ototoxicity/nephrotoxicity: NOT a concern with topical ophthalmic tobramycin — systemic absorption after topical application is negligible (naso-lacrimal drainage delivers small amounts to nasal mucosa but insufficient for systemic toxicity)
- Bacterial conjunctivitis — Gram-negative predominant: tobramycin drops preferred over chloramphenicol in suspected Gram-negative infection (contact lens wearers, post-trauma)
- Culture corneal scrapings before treatment for suspected bacterial keratitis — treatment should be guided by sensitivities when available
Contraindications
- Hypersensitivity to tobramycin or other aminoglycosides
- Herpes simplex keratitis (steroid component of Tobradex may worsen viral keratitis)
Side effects
- Local irritation, stinging, burning
- Eyelid pruritus and oedema
- Conjunctival erythema
- Blurred vision (ointment)
Interactions
- Minimal systemic absorption — no clinically significant interactions
Monitoring
- Response at 48 hours — if no improvement, reassess organism and sensitivities
- Corneal integrity — fluorescein staining for ulceration
Reference: BNFc; BNF 90; RCOphth Microbial Keratitis Guidelines; SPC Tobrex; AAO Preferred Practice Pattern (Bacterial Keratitis). Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- Centor / McIsaac Score for Strep Pharyngitis · Throat
- Ideal Body Weight (Devine) · Anthropometry
- FeverPAIN Score for Strep Throat · Throat
- Jarisch-Herxheimer Reaction Severity Assessment · Treatment Reactions
- PID Severity (CDC Diagnostic Criteria) · Gynaecological Infections
- Gustilo-Anderson Classification (Open Fractures) · Fracture Classification
Pathways
- Acute Red Eye / Vision Loss Screen · RCOphth 2020; NICE CKS
- Idiopathic Intracranial Hypertension · ABN; consensus 2018
- Acute Red Eye Assessment · RCOphth / AAO
- Acute Angle Closure Glaucoma · RCOphth / EGS Guidelines
- Retinal Detachment · RCOphth Guidelines / EURETINA
- Diabetic Retinopathy — Screening and Management · NICE NG28 2016 / NHS DES Programme